Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2010 3
2011 3
2012 1
2013 2
2015 1
2016 1
2017 4
2018 4
2019 16
2020 22
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
Haas RLM, Bonvalot S, Miceli R, Strauss DC, Swallow CJ, Hohenberger P, van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, Fairweather M, Gladdy R, Jakob J, Szacht M, Fiore M, Chung PW, van Houdt WJ, Raut CP, Gronchi A. Haas RLM, et al. Among authors: van houdt wj. Cancer. 2019 Apr 15;125(8):1290-1300. doi: 10.1002/cncr.31927. Epub 2019 Jan 2. Cancer. 2019. PMID: 30602058 Free PMC article.
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Rozeman EA, Menzies AM, van Akkooi ACJ, Adhikari C, Bierman C, van de Wiel BA, Scolyer RA, Krijgsman O, Sikorska K, Eriksson H, Broeks A, van Thienen JV, Guminski AD, Acosta AT, Ter Meulen S, Koenen AM, Bosch LJW, Shannon K, Pronk LM, Gonzalez M, Ch'ng S, Grijpink-Ongering LG, Stretch J, Heijmink S, van Tinteren H, Haanen JBAG, Nieweg OE, Klop WMC, Zuur CL, Saw RPM, van Houdt WJ, Peeper DS, Spillane AJ, Hansson J, Schumacher TN, Long GV, Blank CU. Rozeman EA, et al. Among authors: van houdt wj. Lancet Oncol. 2019 Jul;20(7):948-960. doi: 10.1016/S1470-2045(19)30151-2. Epub 2019 May 31. Lancet Oncol. 2019. PMID: 31160251 Clinical Trial.
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL. Lansu J, et al. Among authors: van houdt wj. JAMA Oncol. 2021 Jan 1;7(1):e205865. doi: 10.1001/jamaoncol.2020.5865. Epub 2021 Jan 21. JAMA Oncol. 2021. PMID: 33180100 Free PMC article.
Neoadjuvant Systemic Treatment of Primary Angiosarcoma.
Heinhuis KM, IJzerman NS, van der Graaf WTA, Kerst JM, Schrage Y, Beijnen JH, Steeghs N, van Houdt WJ. Heinhuis KM, et al. Among authors: van houdt wj. Cancers (Basel). 2020 Aug 12;12(8):2251. doi: 10.3390/cancers12082251. Cancers (Basel). 2020. PMID: 32806524 Free PMC article. Review.
Margins in DFSP Reconsidered: Primum Non Nocere.
van Houdt WJ. van Houdt WJ. Ann Surg Oncol. 2020 Mar;27(3):634-636. doi: 10.1245/s10434-019-08012-4. Epub 2019 Nov 4. Ann Surg Oncol. 2020. PMID: 31686341 No abstract available.
Challenges in sentinel node pathology in the era of adjuvant treatment.
Franke V, Madu MF, Bierman C, Klop WMC, van Houdt WJ, Wouters MWJM, van de Wiel BA, van Akkooi ACJ. Franke V, et al. Among authors: van houdt wj. J Surg Oncol. 2020 Oct;122(5):964-972. doi: 10.1002/jso.26095. Epub 2020 Jun 29. J Surg Oncol. 2020. PMID: 32602119
70 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page